On the basis of the results of several clinical trials, the 2000 Infectious Diseases Society of America guidelines for the management of CM [47] recommended a combination of AmB (0.7–1 mg/kg/day ...

Results: A total of three RCTs involving 1,368 participants (four antifungals) were included. The NMA showed that compared to amphotericin B deoxycholate (D-AmB), the triazoles (posaconazole (POS), ...